Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease
Prima Biomed. Immutep is a leading biotechnology company focused on developing effective autoimmune and cancer immunotherapy treatments such as...
Read Prima-biomed.de news digest here: view the latest Prima Biomed articles and content updates right away or get to their most visited pages. Prima-biomed.de is not yet rated by Alexa and its traffic estimate is unavailable. We haven’t detected security issues or inappropriate content on Prima-biomed.de and thus you can safely use it. Prima-biomed.de is hosted with Neue Medien Muennich GmbH (Germany) and its basic language is English.
- Content verdict: Safe
- Website availability: Live
- Language: English
- Last check:
-
N/A
Visitors daily -
N/A
Pageviews daily -
N/A
Google PR -
N/A
Alexa rank
Best pages on Prima-biomed.de
-
Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease
Immutep is a leading biotechnology company focused on developing effective autoimmune and cancer immunotherapy treatments such as Lag-3.
-
Investor Updates May 2016Investor Update Edition 17[1] February 2016Investor Update Edition 16[2] more[3] Presentation May 2016Canary Stocks to Watch Roadshow, Sydney, Australia[4] April 2016Imm...
-
PRIMA BIOMED - Leadership Team
Leadership Team Frédéric Triebel, MD Ph.D.Chief Scientific Officer & Chief Medical Officer Frédéric Triebel, MD Ph.D., was the scientific founder of Immutep S.A. (2001) and served as the Scientific an...
Domain history
Web host: | Neue Medien Muennich GmbH |
Registrar: | DENIC eG |
Registrant: | |
Updated: | July 12, 2017 |
Expires: | January 01, 1970 |
Created: | January 01, 1970 |
Whois record
Safety scores
Trustworthiness
N/AChild safety
N/A